Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.
UTHR
UNITED THERAPEUTICS CORPData as of 2026 Q1 (03-31) · 13F snapshot
Summary
UNITED THERAPEUTICS CORP (UTHR) is held by 8 tracked hedge-fund managers, a combined reported value of ~$1.89B; the largest are Renaissance Technologies, Ken Griffin, Ken Griffin. This quarter: 3 added, 2 trimmed. 5 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Mixed
Gurus holding8
Congress trades5
Price$545.96vs quarter-end-7.93%
Sectors0
This quarter's moves
Top holderRenaissance TechnologiesNew0
Added3
Trimmed / sold2
Value $102.82M— of portfolio173,4002026 Q1
Value $97.13M— of portfolio163,8002026 Q1
Joel GreenblattHold
Value $47.67M0.1% of portfolio80,3872026 Q1
Value $46.79M— of portfolio78,9002026 Q1
Value $42.99M— of portfolio72,5002026 Q1
Dan LoebNew
Value $24.41M0.8% of portfolio250,0002007 Q4
Value $6.40M— of portfolio10,8002026 Q1
Value $6.29M— of portfolio10,6002026 Q1
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $102.82M | — | — |
| Ken GriffinPUT | $97.13M | — | — |
| Joel Greenblatt | $47.67M | 0.1% | Hold |
| Izzy EnglanderPUT | $46.79M | — | — |
| Izzy EnglanderCALL | $42.99M | — | — |
| Dan Loeb | $24.41M | 0.8% | New |
| Steven CohenCALL | $6.40M | — | — |
| Steven CohenPUT | $6.29M | — | — |